---

title: "Alterations in gut microbiota and associated metabolites in patients with chronic fatigue syndrome"
tags:
- ðŸ§ª Biomarker
created: '2025-12-12'
published: '2025-12-12'

---


<details>
<summary>Cheng et al. (2025)</summary>

- **Authors:** Xinxin Cheng, Wenkuan Wang, Tingting Xu, Yonghui Yin, Yanjie Wang.
- **Institutes:** Affiliated Hospital of Shandong University of Traditional Chinese Medicine.
- **Publisher:** Scientific Reports
- **Link:** [DOI](https://doi.org/10.1038/s41598-025-27564-y)

</details>


## Summary

This research adds to the growing body of evidence that the "gut-brain axis" is central to ME/CFS. By identifying a specific lack of short-chain fatty acidsâ€”which act as fuel for the gut lining and regulate the immune systemâ€”the study provides a potential biological explanation for the systemic inflammation often seen in patients. While it does not offer a cure, it identifies measurable biomarkers that could eventually lead to objective diagnostic tools. Most importantly for patients, it suggests that dietary choices, specifically increasing fiber, might help support the microbiome's production of protective metabolites, though more rigorous clinical trials are needed to confirm the therapeutic benefits.

## What was researched?

This study investigated the differences in the composition of gut bacteria and the levels of their metabolic byproducts, specifically short-chain fatty acids (SCFAs), in people with ME/CFS. Researchers looked for links between these biological markers, the severity of fatigue, and the patients' intake of dietary fiber.

## Why was it researched?

While many ME/CFS patients report gastrointestinal issues, the exact relationship between gut "dysbiosis" (an imbalance of bacteria) and the disease's symptoms remains poorly understood. This research aimed to fill knowledge gaps by exploring whether a deficiency in specific health-promoting metabolites like SCFAsâ€”which help maintain the gut barrierâ€”is a core feature of the illness and how diet might influence this.

## How was it researched?

This was a case-control study involving 80 participants: 40 ME/CFS patients and 40 healthy controls, matched for age and sex. The researchers analyzed stool samples using 16S rRNA gene sequencing to identify bacterial types and Gas Chromatography-Mass Spectrometry (GC-MS) to measure the concentration of six different short-chain fatty acids. Statistical models were used to correlate these biological findings with clinical fatigue scores (FSS and FS-14) and dietary habits.

## What has been found?

The study found that ME/CFS patients have significantly lower bacterial diversity and a distinct "signature" of missing beneficial bacteria, particularly from the *Rikenellaceae* and *Ruminococcaceae* families. Crucially, patients had significantly lower levels of four key SCFAs: acetate, butyrate, isobutyrate, and isovalerate. The reduction in these metabolites was directly linked to higher fatigue severity and lower quality of life scores. Additionally, patients who consumed a high-fiber diet ðŸ’Š had significantly higher levels of acetate and isovalerate compared to those on a low-fiber diet.

## Discussion

The authors suggest that the depletion of SCFA-producing bacteria leads to a "functional deficiency" that may weaken the intestinal barrier, potentially allowing inflammatory substances to enter the bloodstream and trigger systemic symptoms. They acknowledge that while the associations are strong, the study's cross-sectional nature cannot definitively prove that gut changes *cause* ME/CFS. They also highlight that dietary interventions appear to influence these metabolic levels, suggesting a potential pathway for symptom management.

## Conclusion & Future Work

The research concludes that gut dysbiosis and the resulting lack of short-chain fatty acids are significant pathological features of ME/CFS that correlate with symptom severity. The authors call for future longitudinal studies and clinical trials to determine if targeted interventions, such as high-fiber diets or specific prebiotics and probiotics, can effectively restore gut health and alleviate fatigue in this patient population.
